Erika Pintér Selected Research

zucapsaicin

6/2013

Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika Pintér Research Topics

Disease

26	Inflammation (Inflammations) 01/2020 - 05/2004
25	Hyperalgesia 05/2022 - 08/2002
15	Pain (Aches) 01/2020 - 09/2004
13	Arthritis (Polyarthritis) 05/2022 - 05/2004
9	Neurogenic Inflammation 11/2020 - 08/2002
9	Edema (Dropsy) 01/2019 - 05/2007
7	Dermatitis 04/2022 - 12/2005
7	Neuralgia (Stump Neuralgia) 03/2021 - 09/2003
6	Hyperplasia 07/2018 - 05/2007
5	Hypersensitivity (Allergy) 02/2021 - 08/2009
5	Pneumonia (Pneumonitis) 06/2020 - 01/2008
5	Bronchial Hyperreactivity 06/2020 - 05/2007
4	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2016
3	Rheumatoid Arthritis 01/2019 - 10/2014
3	Allergic Contact Dermatitis 01/2016 - 12/2005
3	Colitis 02/2015 - 01/2014
2	Body Weight (Weight, Body) 05/2022 - 04/2022
2	Hypotension (Low Blood Pressure) 01/2022 - 07/2005
2	Hyperglycemia 02/2021 - 03/2016
2	Diabetes Complications 02/2021 - 03/2016
2	Hypertension (High Blood Pressure) 01/2021 - 07/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2018
2	Experimental Arthritis 01/2016 - 07/2005
2	Contact Dermatitis (Eczema, Contact) 01/2016 - 12/2005
2	Burns 06/2013 - 10/2005
1	Disease Progression 04/2022
1	Neuroinflammatory Diseases 01/2022
1	Multiple Sclerosis 12/2021
1	Anosmia 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Diabetes Mellitus 02/2021
1	Metabolic Diseases (Metabolic Disease) 02/2021
1	Cold Hypersensitivity 02/2021

Drug/Important Bio-Agent (IBA)

14	Capsaicin (Zostrix)FDA Link 10/2018 - 05/2004
14	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016 - 08/2002
11	Peroxidase (Myeloperoxidase)IBA 05/2022 - 05/2007
11	NeuropeptidesIBA 09/2016 - 08/2002
8	Analgesics (Analgesic Drugs)IBA 12/2019 - 05/2004
7	AnkyrinsIBA 01/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 04/2022 - 01/2018
6	resiniferatoxinIBA 12/2019 - 09/2003
6	CarrageenanIBA 01/2018 - 10/2005
6	TRPV1 receptorIBA 09/2015 - 07/2005
5	LipopolysaccharidesIBA 06/2020 - 05/2007
5	somatostatin receptor subtype-4IBA 12/2019 - 06/2006
5	TachykininsIBA 01/2017 - 10/2010
5	EndotoxinsIBA 02/2015 - 05/2007
4	Imiquimod (Aldara)FDA LinkGeneric 04/2022 - 01/2018
4	CytokinesIBA 01/2019 - 10/2010
4	Formaldehyde (Formol)FDA Link 01/2018 - 09/2004
4	Peptides (Polypeptides)IBA 01/2016 - 10/2010
4	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 09/2015 - 01/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 08/2009
4	TT2-32IBA 01/2008 - 08/2002
3	Messenger RNA (mRNA)IBA 05/2022 - 12/2009
3	Streptozocin (Streptozotocin)FDA Link 02/2021 - 09/2004
3	Amine Oxidase (Copper-Containing)IBA 02/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 02/2021 - 09/2015
3	EnzymesIBA 02/2021 - 02/2015
3	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 11/2006
3	CuprizoneIBA 12/2019 - 12/2016
3	Substance PIBA 09/2016 - 06/2007
3	Freund's AdjuvantIBA 01/2016 - 05/2004
3	OxazoloneIBA 01/2016 - 08/2009
3	SolutionsIBA 02/2015 - 07/2011
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 05/2014 - 10/2010
2	dimethyl trisulfideIBA 05/2022 - 03/2021
2	Ion Channels (Ion Channel)IBA 05/2022 - 01/2019
2	CreatinineIBA 02/2021 - 03/2016
2	Retinaldehyde (Retinal)IBA 02/2021 - 03/2016
2	Blood Proteins (Serum Proteins)IBA 11/2020 - 01/2012
2	pyrimidineIBA 01/2020 - 12/2019
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 02/2015
2	CollagenIBA 10/2018 - 01/2008
2	SodiumIBA 01/2018 - 02/2015
2	Chemotactic FactorsIBA 01/2017 - 02/2015
2	Ligand-Gated Ion ChannelsIBA 01/2017 - 06/2013
2	GalaninIBA 01/2016 - 01/2016
2	Type 3 Galanin ReceptorIBA 01/2016 - 01/2016
2	Dextran SulfateIBA 02/2015 - 05/2014
2	hemokinin-1IBA 02/2015 - 01/2013
2	Calcitonin Gene-Related PeptideIBA 01/2014 - 06/2007
2	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2009 - 01/2008
2	2S)- 4- amino- N- (1'- carbamoyl- 2'- phenylethyl)- 2- (4''- methyl- 1''- naphthalenesulfonylamino)butanamide (1'SIBA 01/2008 - 06/2006
1	Caffeine (No Doz)FDA LinkGeneric 04/2022
1	9-phenanthrolIBA 01/2022
1	Therapeutic UsesIBA 12/2021
1	Insulin (Novolin)FDA Link 02/2021
1	Oxidoreductases (Dehydrogenase)IBA 02/2021
1	FructosamineIBA 02/2021
1	AminesIBA 02/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021

Therapy/Procedure

8	Ligation 03/2021 - 09/2003
5	Oral Administration 11/2020 - 05/2014
5	Therapeutics 07/2018 - 10/2014
2	Drug Therapy (Chemotherapy) 03/2021 - 10/2019
2	Injections 02/2021 - 01/2018
2	Subcutaneous Injections 01/2008 - 05/2004